Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Novel GSK-3 inhibitor improves behavioral dysfunction in murine model of Alzheimer's disease

July 26, 2011

Phase IIb immunological data disclosed on Bionor Pharma's therapeutic HIV vaccine

July 26, 2011

Phase I safety data on SAM-760 in healthy young and elderly subjects

July 25, 2011

ACS-84 evaluated in rat model of Parkinson's disease

July 25, 2011

Takeda discloses preclinical data on new small-molecule GSK-3 inhibitor for Alzheimer's disease

July 25, 2011

GlaxoSmithKline histamine H3 receptor antagonist shows moderate activity in Alzheimer's disease

July 25, 2011

PET tracer [18F]-SNUBH-NM-333 shows promise in diagnosis of Alzheimer's disease

July 25, 2011

First-in-human trial assesses effects of GSK-1034702 on cognitive function

July 22, 2011

Pfizer's new opioid NOP receptor antagonists show preclinical potential to treat AD

July 22, 2011

Potent serotonin 5-HT4 receptor agonist described by Suven

July 22, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...